Trichomonas Vaginitis clinical trials
The registry lists 22 studies for Trichomonas Vaginitis across 9 countries. 3 are recruiting or about to start. 9 of them are mainly about Trichomonas Vaginitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-24.
Get an email when these change. Save the Trichomonas Vaginitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Population Council (3) · Tulane University Health Sciences Center (2) · University of Alabama at Birmingham (1) · Emory University (1) · Drexel University (1) · Ege University (1) · Johns Hopkins Bloomberg School of Public Health (1) · Agency for Healthcare Research and Quality (AHRQ) (1)
What is being tested here
Drugs under test in Trichomonas Vaginitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Metronidazole | 1 | 1 | 2 |
| Secnidazole | 1 | 0 | 1 |
| Chondrus crispus carrageenan | 0 | 0 | 3 |
Who these studies take
Of the 2 Trichomonas Vaginitis studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (50%) take children under 18. 1 (50%) are for women only and 0 (0%) for men only; 2 (100%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (50%) | 0 (0%) |
| 18 | 2 (100%) | 1 (50%) |
| 30 | 2 (100%) | 1 (50%) |
| 40 | 2 (100%) | 1 (50%) |
| 50 | 2 (100%) | 1 (50%) |
| 65 | 2 (100%) | 1 (50%) |
| 75 | 2 (100%) | 1 (50%) |
| 85 | 2 (100%) | 1 (50%) |
Across all 22 studies, recruiting or not: 32% stop at 75 or younger and 32% at 65; 32% take children; 91% are for women only and 0% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- Improving Maternal and Child Health Through Point-of-care STI TestingRecruitingNCT07290439Not applicable1 country
- Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and SecnidazoleRecruitingNCT06261840Phase 41 country
- Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas VaginitisNot yet recruitingNCT05383521Not applicable1 country
- Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIsCompletedNCT05666778Phase 22 countries
- Point of Care Diagnosis of Vaginal InfectionsCompletedNCT06438575Not applicable1 country
- Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South AfricaCompletedNCT061317491 country
- Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis ConditionsCompletedNCT042196051 country
- Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL OvuleCompletedNCT06056947Phase 31 country
- The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive TractCompletedNCT04189744Phase 31 country
- MAMAS: Mentoring Adolescent Mothers at SchoolCompletedNCT03090802Not applicable1 country
- Evaluation of Efficacy and Safety of Gynomax® XL OvuleCompletedNCT03839875Phase 41 country
- Trichomonas Vaginalis Repeat Infections Among HIV Negative WomenCompletedNCT01832480Phase 31 country
- Trichomonas Vaginalis Genotyping in Upper EgyptStatus unknownNCT03614286
- Neo-Penotran Forte Vaginal Suppository for Vaginal TrichomoniasisCompletedNCT01361048Phase 21 country
- Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedNCT00213031Phase 21 country
- Safety and Acceptability of Carraguard™ Among HIV-negative Couples in ThailandCompletedNCT00213057Phase 11 country
- Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI TransmissionCompletedNCT00213018Phase 21 country
- DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative WomenCompletedNCT018741581 country
- Observational Program Neo-Penotran® ForteCompletedNCT013353731 country
- Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy TestingCompletedNCT009788481 country
- Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research NetworkCompletedNCT00503542Early Phase 11 country
- Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in MalawiCompletedNCT00140764Phase 3